High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer
Abstract Background Acetyl-CoA acetyltransferase 2 (ACAT2) is a lipid metabolism enzyme and rarely was researched in epithelial ovarian cancer (EOC). Methods ACAT2 expressions were confirmed in two pairs of cell lines (A2780 and A2780/DDP, OVCAR8 and OVCAR8/DDP) from Gene Expression Omnibus database...
Saved in:
Main Authors: | Jinfeng Wang (Author), Zhe Yang (Author), Han Bai (Author), Lanbo Zhao (Author), Jing Ji (Author), Yadi Bin (Author), Yu Liu (Author), Siyi Zhang (Author), Huilian Hou (Author), Qiling Li (Author) |
---|---|
Format: | Bog |
Udgivet: |
BMC,
2024-01-01T00:00:00Z.
|
Fag: | |
Online adgang: | Connect to this object online. |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Lignende værker
-
Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer
af: Li-yuan Feng, et al.
Udgivet: (2020) -
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
af: Yan Rong, et al.
Udgivet: (2021) -
ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells
af: Mingjin Wang, et al.
Udgivet: (2023) -
A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
af: Cui Q, et al.
Udgivet: (2021) -
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
af: Nodin Björn, et al.
Udgivet: (2012)